278
Views
108
CrossRef citations to date
0
Altmetric
Review

Early vascular aging (EVA): consequences and prevention

Pages 547-552 | Published online: 06 Jun 2008

References

  • AdaikalakoteswariABalasubramanyamMRavikumarRAssociation of telomere shortening with impaired glucose tolerance and diabetic macroangiopathyAtherosclerosis200719583917222848
  • AdamsJMWhiteMBiological ageing. A fundamental, biological link between socio-economic status and health?Eur J Pub Health200414331415369043
  • AndresdottirMBSigurdssonGSigvaldasonHReykjavik Cohort Study. Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort StudyEur Heart J20022316556312398822
  • ArtandiSETelomeres, telomerase, and human diseaseN Engl J Med20063551195716990382
  • AvivATelomeres, sex, reactive oxygen species, and human cardiovascular agingJ Mol Med2002806899512436345
  • AvivALevyDMangelMGrowth, telomere dynamics and successful and unsuccessful human agingMech Ageing Dev20031248293712875746
  • BainSCGillGVDyerPHCharacteristics of type 1 diabetes of over 50 years duration (the Golden Years Cohort)Diabet Med2003208081114510860
  • Bairey MerzCNDwyerJNordstromCKPsychosocial stress and cardiovascular disease: pathophysiological linksBehav Med200227141712165968
  • BenetosAGardnerJPZureikMShort telomeres are associated with increased carotid atherosclerosis in hypertensive subjectsHypertension200443182514732735
  • BotsMLGrobbeeDEIntima media thickness as a surrogate marker for generalised atherosclerosisCardiovasc Drugs Ther2002163415112652104
  • BrouiletteSSinghRKThompsonJRWhite cell telomere length and risk of premature myocardial infarctionArterioscler Thromb Vasc Biol200323842612649083
  • BrouiletteSWMooreJSMcMahonADWest of Scotland Coronary Prevention Study GroupTelomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control studyLancet20073691071417223473
  • CawthonRMSmithKRO’BrienEAssociation between telomere length in blood and mortality in people aged 60 years or olderLancet2003361393512573379
  • ChandolaTBrunnerEMarmotMChronic stress at work and the metabolic syndrome: prospective studyBMJ2006332521516428252
  • CherkasLFAvivAValdesAMThe effects of social status on biological aging as measured by white-blood-cell telomere lengthAging Cell20065615
  • [CTT] Cholesterol Treatment Trialists’ CollaboratorsEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statinsLancet200536612677816214597
  • [CRESCENDO] Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes; Sanofi-AventisComprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes (CRESCENDO) [online]2005 Accessed on October 10, 2007. URL: http://clinicaltrials.gov/ct/show/NCT00263042?order=1
  • DagenaisGRPogueJFoxKAngiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trialsLancet2006368581816905022
  • DanaeiGLawesCMVander HoornSGlobal and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessmentLancet20063681651917098083
  • [DGI] Diabetes Genetics Initiative of Broad Institute of Harvard and IMT, Lund University and NOVARTIS Institutes for Biomedical ResearchGenome-wide association analysis identifies three novel loci for type-2 diabetes and one for triglyceride levelsScience20073161331617463246
  • EdwardGLakattaEGNajjarSSVascular aging: An emerging new global cardiovascular risk. The Valencia Forum [abstract online]2002 Accessed on October 10, 2007. URL: http://www.valenciaforum.com/Keynotes/el.html
  • EpelESBlackburnEHLinJAccelerated telomere shortening in response to life stressProc Natl Acad Sci USA2004101173121515574496
  • FitzpatrickALKronmalRAGardnerJPLeukocyte telomere length and cardiovascular disease in the Cardiovascular Health StudyAm J Epidemiol2007165142117043079
  • FusterJJDiezJAndrèsVTelomere dysfunction and hypertensionJ Hypertens20072521859217921808
  • GardnerJPLiSSrinivasanSRRise in insulin resistance is associated with escalated telomere attritionCirculation20051112171715851602
  • GrahamIAtarDBorch-JohnsenKEuropean guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)Eur Heart J200728237541417726041
  • HanssonGKInflammation, atherosclerosis, and coronary artery diseaseN Engl J Med200535216859515843671
  • HedbladBNilssonPErikssonK-FRisk factor pattern and prevalence of atherosclerotic disease in subjects with the metabolic syndrome. Data from the Malmö Diet and Disease StudyDiabetic Medicine20001729930710821297
  • HedbladBWikstrandJJanzonLLow-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS)Circulation20011031721611282901
  • HedbladBNilssonPMZambaniniARosiglitazone reduces carotid intima-media thickness progression over 1 year in patients with type 2 diabetes but not in non-diabetic people who have insulin resistance aloneJ Internal Med200726129330517305652
  • HomePDPocockSJBeck-NielsenHRosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocolDiabetologia20054817263516025252
  • HuGJousilahtiPQiaoQSex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarctionDiabetologia2005488566115827741
  • JarvisaloMJJuonalaMRaitakariOTAssessment of inflammatory markers and endothelial functionCurr Opin Clin Nutr Metab Care200695475216912549
  • JorenbyDEHaysJTRigottiNAVarenicline Phase 3 Study GroupEfficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trialJAMA2006296566316820547
  • KaplanGAKeilJESocio-economic factors and cardiovascular disease: a review of the literatureCirculation1993881973988403348
  • LaurentSCockkroftJVan BortelLExpert consensus document on arterial stiffness: methodological issues and clinical applicationsEur Heart J200627258860517000623
  • LeesonCPHingoraniADMullenMJGlu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial functionCirc Res2002901153812065317
  • MarmotMHealth in an unequal worldLancet200636820819417161730
  • NajjarSSScuteriALakattaEGArterial aging: is it an immutable cardiovascular risk factor?Hypertension2005464546216103272
  • NathanDMBuseJBDavidsonMBManagement of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care20062919637216873813
  • NilssonPPremature ageing – the link between psychosocial risk factors and disease?Med Hypotheses19964739428819115
  • NilssonPMNilssonJ-ÅBerglundGFamily burden of cardiovascular mortality – risk implications for offspring in a national register linkage study based upon the Malmö Preventive ProjectJ Intern Med20042552293514746560
  • NilssonPMEngbergMNilssonJ-ÅAdverse social factors predict early ageing in middle-aged men and women: the Ebeltoft Health Study, DenmarkScand J Public Health20053116
  • NilssonPMEngströmGHedbladBPlasma adiponectin levels are inversely associated with carotid intima media thickness and markers of insulin resistance in middle-aged menATVB200626275862
  • ObanaNTakagiSKinouchiYTelomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disordersIntern Med200342150312636233
  • OgamiMIkuraYOhsawaMTelomere shortening in human coronary artery diseasesArterioscler Thromb Vasc Biol2004245465014726417
  • PlavinskiSLPlavinskayaSIKlimovANSocial factors and increase in mortality in Russia in the 1990s: prospective cohort studyBMJ20033261240212791737
  • RietzschelERDe BuyzereMLBekaertSAsklepios InvestigatorsRationale, design, methods and baseline characteristics of the Asklepios StudyEur J Cardiovasc Prev Rehab20071417991
  • RimmEBChanJStampferMJProspective study of cigarette smoking, alcohol use, and the risk of diabetes in menBMJ199531055597888928
  • RosvallMÖstergrenPOHedbladBOccupational status, educational level, and the prevalence of carotid atherosclerosis in a general population sample of middle-aged Swedish men and women: results from the Malmo Diet and Cancer StudyAm J Epidemiol20001523344610968378
  • RosvallMJanzonLBerglundGIncidence of stroke is related to carotid IMT even in the absence of plaqueAtherosclerosis2005a1793253115777549
  • RosvallMJanzonLBerglundGIncident coronary events and case fatality in relation to common carotid intima-media thicknessJ Intern Med2005b257430715836659
  • RosvallMÖstergrenPOHedbladBSocioeconomic differences in the progression of carotid atherosclerosis in middle-aged men and women with subclinical atherosclerosis in SwedenSoc Sci Med20066217859816181715
  • RydénLStandlEBartnikMTask Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC)European Association for the Study of Diabetes (EASD)Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)Eur Heart J2007288813617220161
  • SamaniNJBoultbyRButlerRTelomere shortening in atherosclerosisLancet2001358472311513915
  • ShanHYBaiXJChenXMApoptosis is involved in the senescence of endothelial cells induced by angiotensin IICell Biol Int2007919 Epub ahead of print
  • StamlerJVaccaroONeatonJDDiabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialDiabetes Care199316434448432214
  • SundquistKLiXDifferences in maternal and paternal transmission of coronary heart diseaseAm J Prev Med200630480616704941
  • TaddeiSVirdisAMatteiPHypertension causes premature aging of endothelial function in humansHypertension199729736439052889
  • TeoKYusufSSleightPONTARGET/TRANSCEND InvestigatorsRationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trialsAm Heart J2004148526115215792
  • TeoKKOunpuuSHawkenSINTERHEART Study InvestigatorsTobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control studyLancet20063686475816920470
  • ValdesAMAndrewTGardnerJPObesity, cigarette smoking, and telomere length in womenLancet2005366662416112303